{
  "DOI": "10.1186/s40246-016-0061-7",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-016-0061-7",
  "alternative-id": [
    "61"
  ],
  "article-number": "4",
  "author": [
    {
      "affiliation": [],
      "family": "Patterson",
      "given": "Sara E.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Rangjiao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Statz",
      "given": "Cara M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Durkin",
      "given": "Daniel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lakshminarayana",
      "given": "Anuradha",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mockus",
      "given": "Susan M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        1,
        16
      ]
    ],
    "date-time": "2016-01-16T03:22:04Z",
    "timestamp": 1452914524000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        9,
        3
      ]
    ],
    "date-time": "2019-09-03T19:04:09Z",
    "timestamp": 1567537449000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        2
      ]
    ],
    "date-time": "2024-05-02T06:34:53Z",
    "timestamp": 1714631693653
  },
  "is-referenced-by-count": 103,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2016,
        1,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2016,
          12
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-016-0061-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2016,
        1,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        1,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1093/nar/gku1075",
      "author": "SA Forbes",
      "doi-asserted-by": "crossref",
      "first-page": "D805",
      "issue": "Database issue",
      "journal-title": "Nucleic Acids Res",
      "key": "61_CR1",
      "unstructured": "Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43(Database issue):D805–811.",
      "volume": "43",
      "year": "2015"
    },
    {
      "key": "61_CR2",
      "unstructured": "My Cancer Genome. Vanderbilt-Ingram Cancer Center. http://www.mycancergenome.org . Accessed 20 Oct 2015."
    },
    {
      "DOI": "10.1093/nar/gku1071",
      "author": "KA Gray",
      "doi-asserted-by": "crossref",
      "first-page": "D1079",
      "issue": "Database issue",
      "journal-title": "Nucleic Acids Res 2015",
      "key": "61_CR3",
      "unstructured": "Gray KA, Yates B, Seal RL, Wright MW, Bruford EA. Genenames.org: the HGNC resources in. Nucleic Acids Res 2015. 2015;43(Database issue):D1079–1085.",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(200001)15:1\u003c7::AID-HUMU4\u003e3.0.CO;2-N",
      "author": "JT Dunnen den",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "journal-title": "Hum Mutat",
      "key": "61_CR4",
      "unstructured": "den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15:7–12.",
      "volume": "15",
      "year": "2000"
    },
    {
      "DOI": "10.1038/nbt.2940",
      "author": "Y Yuan",
      "doi-asserted-by": "crossref",
      "first-page": "644",
      "journal-title": "Nat Biotechnol",
      "key": "61_CR5",
      "unstructured": "Yuan Y, Van Allen EM, Omberg L, Wagle N, Amin-Mansour A, Sokolov A, et al. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol. 2014;32:644–52.",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.yexmp.2014.12.009",
      "author": "G Ananda",
      "doi-asserted-by": "crossref",
      "first-page": "106",
      "journal-title": "Exp Mol Pathol",
      "key": "61_CR6",
      "unstructured": "Ananda G, Mockus S, Lundquist M, Spotlow V, Simons A, Mitchell T, et al. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors. Exp Mol Pathol. 2015;98:106–12.",
      "volume": "98",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s00335-015-9576-9",
      "author": "LM Schriml",
      "doi-asserted-by": "crossref",
      "first-page": "584",
      "journal-title": "Mamm Genome Off J Int Mamm Genome Soc",
      "key": "61_CR7",
      "unstructured": "Schriml LM, Mitraka E. The Disease Ontology: fostering interoperability between biological and clinical human disease-related data. Mamm Genome Off J Int Mamm Genome Soc. 2015;26:584–9.",
      "volume": "26",
      "year": "2015"
    },
    {
      "DOI": "10.1373/clinchem.2015.247437",
      "doi-asserted-by": "crossref",
      "key": "61_CR8",
      "unstructured": "Mockus S, Patterson S, Statz C, Bult C, Tsongalis G. Clinical trials in precision oncology. Clin Chem. 2015.247437. [Epub ahead of print]"
    },
    {
      "DOI": "10.1016/j.ctrv.2015.02.009",
      "author": "N Roper",
      "doi-asserted-by": "crossref",
      "first-page": "385",
      "journal-title": "Cancer Treat Rev",
      "key": "61_CR9",
      "unstructured": "Roper N, Stensland KD, Hendricks R, Galsky MD. The landscape of precision cancer medicine clinical trials in the United States. Cancer Treat Rev. 2015;41:385–90.",
      "volume": "41",
      "year": "2015"
    },
    {
      "DOI": "10.2147/TCRM.S50526",
      "author": "S Maio Di",
      "doi-asserted-by": "crossref",
      "first-page": "873",
      "journal-title": "Ther Clin Risk Manag",
      "key": "61_CR10",
      "unstructured": "Di Maio S, Yip S, Al Zhrani GA, Alotaibi FE, Al Turki A, Kong E, et al. Novel targeted therapies in chordoma: an update. Ther Clin Risk Manag. 2015;11:873–83.",
      "volume": "11",
      "year": "2015"
    },
    {
      "author": "R Ramakrishna",
      "first-page": "612",
      "journal-title": "J Clin Neurosci Off J Neurosurg Soc Australas",
      "key": "61_CR11",
      "unstructured": "Ramakrishna R, Rostomily R, Sekhar L, Rockhill J, Ferreira M. Hemangiopericytoma: radical resection remains the cornerstone of therapy. J Clin Neurosci Off J Neurosurg Soc Australas. 2014;21:612–5.",
      "volume": "21",
      "year": "2014"
    },
    {
      "DOI": "10.4103/0973-1482.163698",
      "author": "M Sana",
      "doi-asserted-by": "crossref",
      "first-page": "508",
      "journal-title": "J Cancer Res Ther",
      "key": "61_CR12",
      "unstructured": "Sana M, Malik HJ. Current and emerging breast cancer biomarkers. J Cancer Res Ther. 2015;11:508–13.",
      "volume": "11",
      "year": "2015"
    },
    {
      "DOI": "10.2147/OTT.S39096",
      "author": "F Spagnolo",
      "doi-asserted-by": "crossref",
      "first-page": "157",
      "journal-title": "OncoTargets Ther",
      "key": "61_CR13",
      "unstructured": "Spagnolo F, Ghiorzo P, Orgiano L, Pastorino L, Picasso V, Tornari E, et al. BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. OncoTargets Ther. 2015;8:157–68.",
      "volume": "8",
      "year": "2015"
    },
    {
      "DOI": "10.1038/bjc.2015.356",
      "doi-asserted-by": "crossref",
      "key": "61_CR14",
      "unstructured": "Kuan F-C, Kuo L-T, Chen M-C, Yang C-T, Shi C-S, Teng D, et al. Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis. Br J Cancer. 2015;113(10):1519-28."
    },
    {
      "DOI": "10.1002/cncr.29493",
      "doi-asserted-by": "crossref",
      "key": "61_CR15",
      "unstructured": "Naidoo J, Sima CS, Rodriguez K, Busby N, Nafa K, Ladanyi M, et al. Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib. Cancer. 2015;121(18):3212-20."
    },
    {
      "DOI": "10.1126/scitranslmed.3007205",
      "author": "H Yasuda",
      "doi-asserted-by": "crossref",
      "first-page": "216ra177",
      "journal-title": "Sci Transl Med",
      "key": "61_CR16",
      "unstructured": "Yasuda H, Park E, Yun C-H, Sng NJ, Lucena-Araujo AR, Yeo W-L, et al. Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer. Sci Transl Med. 2013;5:216ra177.",
      "volume": "5",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0119832",
      "author": "YJ Choi",
      "doi-asserted-by": "crossref",
      "first-page": "e0119832",
      "journal-title": "PloS One",
      "key": "61_CR17",
      "unstructured": "Choi YJ, Kim SY, So KS, Baek I-J, Kim WS, Choi SH, et al. AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cells. PloS One. 2015;10:e0119832.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1093/nar/gku1055",
      "author": "GR Brown",
      "doi-asserted-by": "crossref",
      "first-page": "D36",
      "issue": "Database issue",
      "journal-title": "Nucleic Acids Res",
      "key": "61_CR18",
      "unstructured": "Brown GR, Hem V, Katz KS, Ovetsky M, Wallin C, Ermolaeva O, et al. Gene: a gene-centered information resource at NCBI. Nucleic Acids Res. 2015;43(Database issue):D36–42.",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1186/2041-1480-5-7",
      "author": "V Petri",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "journal-title": "J Biomed Semant",
      "key": "61_CR19",
      "unstructured": "Petri V, Jayaraman P, Tutaj M, Hayman GT, Smith JR, De Pons J, et al. The pathway ontology—updates and applications. J Biomed Semant. 2014;5:7.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-1455",
      "author": "DB Costa",
      "doi-asserted-by": "crossref",
      "first-page": "7060",
      "journal-title": "Clin Cancer Res Off J Am Assoc Cancer Res",
      "key": "61_CR20",
      "unstructured": "Costa DB, Nguyen K-SH, Cho BC, Sequist LV, Jackman DM, Riely GJ, et al. Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:7060–7.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1634/theoncologist.2012-0262",
      "author": "KW Robinson",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "The Oncologist",
      "key": "61_CR21",
      "unstructured": "Robinson KW, Sandler AB. The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agents. The Oncologist. 2013;18:115–22.",
      "volume": "18",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ccr.2009.11.022",
      "author": "AB Turke",
      "doi-asserted-by": "crossref",
      "first-page": "77",
      "journal-title": "Cancer Cell",
      "key": "61_CR22",
      "unstructured": "Turke AB, Zejnullahu K, Wu Y-L, Song Y, Dias-Santagata D, Lifshits E, et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell. 2010;17:77–88.",
      "volume": "17",
      "year": "2010"
    },
    {
      "key": "61_CR23",
      "unstructured": "Mancini M, Yarden Y. Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. Semin Cell Dev Biol. 2015;pii: S1084-9521(15)00178-0. [Epub ahead of print]."
    },
    {
      "DOI": "10.1073/pnas.0701005104",
      "author": "M Gymnopoulos",
      "doi-asserted-by": "crossref",
      "first-page": "5569",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "61_CR24",
      "unstructured": "Gymnopoulos M, Elsliger M-A, Vogt PK. Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci U S A. 2007;104:5569–74.",
      "volume": "104",
      "year": "2007"
    }
  ],
  "reference-count": 24,
  "references-count": 24,
  "resource": {
    "primary": {
      "URL": "http://www.humgenomics.com/content/10/1/4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "10"
}